Labcorp's AI-powered platform that was developed in collaboration with AWS and Datavant allows researchers and pharmaceutical companies to access large datasets and advanced analytics. The main goal of this program is to streamline the analysis of patient journeys, treatment patterns, and disease progression. Speeding up this process would also lead to faster drug development to improve patient health. Although the program's main focus is Alzheimer's research, they are planning to extend into fields like women's health, oncology, and cardiometabolic